Schedule 13G ownership disclosure
Frazier Life Sciences Acquisition Corp. II
Class A Ordinary Shares, par value $0.0001 per share · CUSIP: G37103101
Event date: 2026-10-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 700,000.00 · Class: 9.0%
- Peter Kolchinsky
Shares: 700,000.00 · Class: 9.0%
- Rajeev Shah
Shares: 700,000.00 · Class: 9.0%
- RA Capital Healthcare Fund, L.P.
Shares: 700,000.00 · Class: 9.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-26-000245
- Form type
- SCHEDULE 13G
- Filer
- Frazier Life Sciences Acquisition Corp. II
- CIK
- CIK 2153598
- Filed
- Oct 22, 2026
- Reporting period
- Oct 15, 2026
- Description
- Schedule 13G beneficial ownership